35 studies found for: HIV [CONDITION] AND (pregnancy OR perinatal) [TREATMENT] | Open Studies
Integrating HIV and Depression Self-Care to Improve Adherence in Perinatal Women
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Support for Perinatal Adherence and Depression
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women
The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy
Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
|10||Not yet recruiting||
PrEP Implementation for Mothers in Antenatal Care
Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria
Evaluation of an Integrated Economic Strengthening and HIV Prevention Program for Vulnerable Youth in South Africa
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
Family Planning and HIV in Postpartum Women in Mbarara
Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors
Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India
|20||Not yet recruiting||
Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants
† Study has passed its completion date and status has not been verified in more than two years.